Nipro newsletter April 2026
tjoapck banner – feb 2026
Carterra 23/09/25
LB Bohle – 10.06.2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Merxin March 2026
Chemspec Feb 2026
the bridge – website ad 28/01/2026
Terumo 05/01
Nipro April 2026
SAE Media – Pre-filled syringes West Coast 19/11/25
A Winner Emerges in the War Against Microbes
Clinical Research v4i4

A Winner Emerges in the War Against Microbes

Man has benefited from copper’s inherent antimicrobial properties since the dawn of civilisation, yet it is only in the last 10-20 years that scientific studies ...
Continue Reading →
Cytomics: Managing Biocomplexity in Drug Development, Clinical Diagnostics, and Clinical Medicine
Clinical Research v4i4

Cytomics: Managing Biocomplexity in Drug Development, Clinical Diagnostics, and Clinical Medicine

Cytomics, the science of analysis at the cellular level, objectively accounts for functional phenotypes in the context of the entire organism. Furthermore, ...
Continue Reading →
Conducting Non-clinical Studies with Protein Biologics: Considerations in Test Article Characterisation and Method Development for Dose Formulation Analysis
Clinical Research v4i4

Conducting Non-clinical Studies with Protein Biologics: Considerations in Test Article Characterisation and Method Development for Dose Formulation Analysis

With the increase in the number of protein biologics in development, including monoclonal antibodies, the proportion of GLP studies conducted for protein test ar...
Continue Reading →
One year after the United Nations Summit on Noncommunicable Diseases (NCDs): New Opportunities and  Challenges in the Fight Against NCDs
Clinical Research v4i4

One year after the United Nations Summit on Noncommunicable Diseases (NCDs): New Opportunities and Challenges in the Fight Against NCDs

This past year has seen tremendous progress on NCDs at the global level, most notably with the adoption of a global target to reduce premature deaths from NCDs i...
Continue Reading →
SMI London
Biopharma group march 2026
Interpack Staubli March 2026
Silgan March 2026
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
Aptar – 08/01/2026
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025